“wende-hutton” Archives

in
Entry Author Date Location
Q3 Venture Funding Surges Near Record Levels, and Top 10 Deals 10/16/15 National
Crossing Sand Hill: A Q&A With Biotech Venture Vet Nina Kjellson 09/30/15 San Francisco
Out of the Digital Health Fog, More Investments Are Coming in 2015 06/29/15 National
Glooko Gets $16M Injection to Upgrade Digital Diabetes Product 03/17/15 San Francisco
West Coast Biotech Roundup: Pharmacyclics, Gates, Ikaria & More 03/05/15 San Francisco
“Voice for Everyone”—Life-Sci Women Talk Venture, Pharma Gender Gap 03/04/15 San Francisco
In the Jiu-Jitsu Match of Biotech Risk, a Reminder of Other Paths 01/20/15 National
As Atlas Splits, Is There A Case To Make In Venture For Specialists? 10/22/14 National
Canaan Closes $675M Fund, One Of Venture’s Ten Largest This Year 10/16/14 New York
Which VCs Are Poised to Profit From the Biotech IPO Boom? 09/09/13 National
West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News 04/21/11 San Diego
In This Corner: Kinsella & More Vs. Hutton & Samuels on Venture Biotech 04/18/11 San Diego
As Kinsella Affair Goes Global, Sofinnova’s Papiernik Says Don’t Blame Big Pharma for Weak Biotech Ventures 03/30/11 San Diego
Canaan Strings Together Some Good News, Just as the Pressure Mounts on VC Model 03/24/11 San Francisco
Page 1 of 1